Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

The Joint Corp Performed 14.7M Patient Visits In 2024, Compared To 13.6M In 2023

Author: Benzinga Newsdesk | January 16, 2025 08:23am

2024 Full Year Operating Highlights

Performed 14.7 million patient visits, compared to 13.6 million in 2023.
Treated 957,000 new patients, compared to 932,000 in 2023.
Increased system-wide sales1 9%, compared to 12% in 2023.
Delivered comp sales2 of 4% on par with 4% in 2023.
Sold 46 franchise licenses, compared to 55 in 2023.
Expanded total clinic count to 967, up from 935 clinics at December 31, 2023.
- Opened 57, refranchised 3, and closed 18 (including 3 relocations) for a total of 842 franchised clinics at December 31, 2024, compared to 800 at December 31, 2023.
- Refranchised 3 and closed 7 (including three non-traditional corporate units on Airforce bases) for a total of 125 company-owned or managed clinics at December 31, 2024, compared to 135 at December 31, 2023.

Posted In: JYNT